For citations:
Pravkina E.A., Pereverzeva K.G., Yakushin S.S., Mylnikov P.Yu., Chekanova E.G., Degtiareva T.S., Shchulkin A.V. A comparative study of the therapeutic equivalence (efficacy, safety, and tolerability) and pharmacokinetics of brand-name and generic rivaroxaban in patients with non-valvular atrial fibrillation. Rational Pharmacotherapy in Cardiology. 2025;21(6):552-562. (In Russ.) https://doi.org/10.20996/1819-6446-2025-3266
JATS XML
Email this article 